Lipid-based nanoparticles (LNPs) efficiently deliver therapeutic RNA payloads and can be rapidly scaled up through cell-free production processes. However, their complex structure presents analytical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results